Sign in

CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company

TENAX THERAPEUTICS, INC.

Sign in to watch
Ticker
TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
262593535
Phone
919-855-2100
Business address
101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
Former names
OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
Open-market buys, last 90 days
$6,396,312
in 7 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$6,396,312. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-07-31 Jebsen Michael B CFO Returned to the company +49 $3.68 $180 68,084
2015-05-15 Jebsen Michael B CFO Returned to the company +430 $3.42 $1K 68,133
2015-05-15 Jebsen Michael B CFO Returned to the company +55 $3.44 $189 67,703
2015-02-13 Jebsen Michael B CFO Returned to the company +56 $3.28 $184 67,758
2015-01-20 BLANCK RONALD R Director Purchase +2,000 $3.49 $7K 10,199
2014-10-31 Jebsen Michael B CFO Returned to the company +49 $3.94 $193 67,814
2014-07-31 Jebsen Michael B CFO Returned to the company +50 $3.91 $196 67,863
2014-07-15 Jebsen Michael B Chief Financial Officer Returned to the company +14,761 $4.67 $69K 67,483
2014-05-01 Jebsen Michael B Chief Finanacial Officer Grant or award +430 $4.98 $2K 67,913
2014-04-15 Jebsen Michael B Chief Financial Officer Returned to the company +15 $5.55 $83 82,244
2014-03-15 Jebsen Michael B President and CFO Returned to the company +16 $6.47 $104 82,259
2014-02-15 Jebsen Michael B Chief Financial Officer Returned to the company +16 $6.18 $99 50,132
2014-01-15 Jebsen Michael B Chief Financial Officer Returned to the company +16 $4.50 $72 50,148
2013-12-15 Jebsen Michael B Chief Financial Officer Returned to the company +14 $6.27 $88 50,164
2013-11-15 Jebsen Michael B Chief Financial Officer Returned to the company +14 $3.04 $43 50,178
2013-11-13 Jebsen Michael B Chief Financial Officer Grant or award +32,143 $7.00 $225K 82,335
2013-11-13 Kelley John P Chief Executive Officer Grant or award +341,711 341,711
2013-11-13 Kelley John P Chief Executive Officer Grant or award +8,248 8,248
2013-10-15 Jebsen Michael B Chief Financial Officer Returned to the company +14 $1.47 $21 50,192
2013-10-04 Jebsen Michael B Chief Financial Officer Grant or award +79,546 $1.32 $105K 50,206

Page 10 of 16 · 316 trades